RESEARCH ALERT-Oncolytics Biotech: Paradigm cuts target price

Fri Nov 22, 2013 6:37am EST
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Nov 22 (Reuters) - Oncolytics Biotech Inc : * Paradigm cuts target price to C$10 from C$12; rating buy For a summary of rating and price target changes on U.S. companies: Reuters Eikon users, click on Reuters 3000Xtra users, double-click Thomson ONE users, type in RT/RCH/US For a summary of rating and price target changes on Canadian companies: Reuters Eikon users, click on Reuters 3000Xtra users, double-click Thomson ONE users, type in RT/RCH/CA